Luchsinger, Larry
New York Blood Center
3 papers on CoChatORCID 0000-0002-0063-1764
Most cited papers
- Verified
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., et al. (2020) · eLife
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 1,308
- Verified
A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
Tai, W., Zhang, X., Drelich, A., Shi, J., Hsu, J. C., Luchsinger, L., Hillyer, C. D., Tseng, C.-T. K., Jiang, S., & Du, L. (2020) · Cell Research
SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing
Cited by 151
- Verified
Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts
Luchsinger, L. L., Patenaude, C. A., Smith, B. D., & Layne, M. D. (2011) · Journal of Biological Chemistry
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments
Cited by 127
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free